Cargando…
The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation
Optimizing antithymocyte globulin (rATG) dosage is critical for high immunological risk patients undergoing a repeat kidney transplant. This natural retrospective cohort study compared clinical outcomes of two successive cohorts of consecutive recipients of retransplants receiving 5 x 1 mg/kg (rATG-...
Autores principales: | Linhares, Kamilla, Taddeo, Julia Bernardi, Cristelli, Marina Pontello, Proença, Henrique, Ficher, Klaus Nunes, de Marco, Renato, Gerbase-DeLima, Maria, Medina-Pestana, Jose, Tedesco-Silva, Helio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115839/ https://www.ncbi.nlm.nih.gov/pubmed/33979389 http://dx.doi.org/10.1371/journal.pone.0251384 |
Ejemplares similares
-
The impact of universal induction therapy on early hospital
readmission of kidney transplant recipients
por: Tavares, Melissa Gaspar, et al.
Publicado: (2022) -
Two-Hit Kidney Allograft Injury by SARS-CoV-2
por: Ribeiro, Bárbara, et al.
Publicado: (2023) -
Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes
por: Teixeira, Cínthia Montenegro, et al.
Publicado: (2020) -
Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes
por: Gerbase-DeLima, Maria, et al.
Publicado: (2020) -
Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019)